Background. Radiofrequency energy has been used safely and successfully to eliminate accessory pathways in patients with the Wolff-Parkinson-White syndrome and the substrate for atrioventricular nodal reentrant tachycardia. However, this form of ablation has had only limited success in eliminating ventricular tachycardia in patients with structural heart disease. In contrast, direct-current catheter ablation has been used successfully to eliminate ventricular tachycardia in patients with and without structural heart disease. Conclusions. Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease is effective and safe and may be considered as early therapy in these patients. (Circulation 1992;85:1666-1674 
Background. Radiofrequency energy has been used safely and successfully to eliminate accessory pathways in patients with the Wolff-Parkinson-White syndrome and the substrate for atrioventricular nodal reentrant tachycardia. However, this form of ablation has had only limited success in eliminating ventricular tachycardia in patients with structural heart disease. In contrast, direct-current catheter ablation has been used successfully to eliminate ventricular tachycardia in patients with and without structural heart disease. The purpose of this study was to test whether radiofrequency energy can safely and effectively ablate ventricular tachycardia in patients without structural heart disease.
Methods and Results. Sixteen patients (nine women and seven men; mean age, 38 years; range, 18-55 years) without structural heart disease who had ventricular tachycardia underwent radiofrequency catheter ablation to eliminate the ventricular tachycardia. Two patients presented with syncope, nine with presyncope, and five with palpitations only. Mean duration of symptoms was 6.7 years (range, 0.5-20 years). Radiofrequency catheter ablation successfully eliminated ventricular tachycardia in 15 of 16 patients (94%). Sites of ventricular tachycardia origin included the high right ventricular outflow tract (12 patients) , the right ventricular septum near the tricuspid valve (three patients), and the left ventricular septum (one patient). The only ablation failure was in a patient whose ventricular tachycardia arose from a region near the His bundle. An accurate pace map, early local endocardial activation, and firm catheter contact with endocardium were associated with successful ablation. Radiofrequency ablation did not cause arrhythmias, produced minimal cardiac enzyme rise, and resulted in no detectable change in cardiac function by Doppler echocardiography.
Conclusions. Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease is effective and safe and may be considered as early therapy in these patients. (Circulation 1992; 85:1666 -1674 KEY WoRDs * ventricular tachycardia * ablation * radiofrequency current E limination of all or part of the anatomical substrate responsible for supraventricular tachycardia in patients with the Wolff-ParkinsonWhite syndrome1-6 and atrioventricular (AV) nodal reentry7-10 with the use of radiofrequency (RF) energy has been reported with a high success rate and few complications. However, equivalent success was not achieved in patients with ventricular tachycardia (VT)1'-16 by using either direct-current or RF energy unless the mechanism of VT was bundle branch reentry.1718 Failure to eliminate VT by using RF energy delivered through a catheter in patients with coronary artery disease may be due to the small size and the shallow depth created by the RF lesion,19,20 which prevents it from reaching subendocardial (or deeper) regions of the heart. Contributing factors could also include inaccurate mapping in scarred ventricles or a location of the VT focus or pathways at sites deep to the endocardium. Successful elimination of idiopathic (usually right ventricular) VT21-24 in patients without structural heart disease with direct-current countershocks has been reported. 25 However, barotrauma, risk of ventricular perforation, and other potential complications associated with direct-current countershocks make this technique less desirable unless very low energies are used.
The purpose of this study was to test the hypothesis that the endocardial lesion caused by RF energy would eliminate a myocardial focus responsible for VT in patients with idiopathic VT associated with a structurally normal heart. A successful outcome would help establish one or all of the following: transmission of RF energy to the focus unimpeded by damaged endocardium, accurate mapping, and location of the focus in or near the endocardium. ance. RF current was delivered at 40-60 V (usually 50-55 V) between the large-tip catheter electrode and a standard electrosurgical adhesive pad applied to the chest wall. Energy was applied during VT when possible; otherwise, it was delivered during spontaneous rhythm for 30-60 seconds but was terminated immediately when an impedance rise occurred. Programmed electrical stimulation (with and without isoproterenol infusion) was repeated 30 minutes after ablation and again 6 weeks later. Successful ablation was defined as abolition of spontaneous and inducible (premature stimulation and/or isoproterenol) VT.
Signal-averaged ECGs were obtained before the ablation procedure and again 6 weeks later; they were analyzed in the time domain using standard criteria.26,27 The two-dimensional echocardiogram/Doppler studies were obtained before ablation and 24 hours after the procedure. Mitral valve prolapse was defined as being present when a portion of the body of the mitral valve leaflet was displaced to the atrial side of a line drawn between the aortic-mitral fibrosa and the mitral posterior wall annulus in the parasternal long-axis view. Right ventricular dysplasia was defined echocardiographically as a dilated right ventricle that was equal to or larger than the left ventricle. Associated findings included areas of hypokinesis or overt thinning. Creatine phosphokinase (CPK) isozymes were obtained on three occasions, immediately after ablation and at 8-hour intervals thereafter. Only patient 4 received heparin during the procedure because the ablation catheter tip was in the left ventricle. All patients received heparin for 24-48 hours after ablation. There were no hemorrhagic complications.
Results

Presenting Arrhythmia
The mean ventricular tachycardia cycle length was 323+±54 msec and ranged from 250 to 400 msec. The ventricular tachycardia morphology was that of a left bundle branch block with an inferior axis in 13 patients, left bundle branch block with a rightward axis in two patients, and right bundle branch block with a superior axis in one patient. Except for patients 8 (Figure 2 ). Of the eight patients presenting with sustained VT, five had sustained VT at the electrophysiology study. The remaining three patients (patients 1, 8, and 10) had only nonsustained VT at the study. Of the seven patients presenting with nonsustained VT, six had nonsustained VT at the electrophysiology study and one had only PVCs at the study. The one patient (patient 12) with incessant nonsustained VT had this arrhythmia at the electrophysiology study. (See Table 1 .)
Response to Isoproterenol
Of the five patients with sustained VT induced at the electrophysiology study, three had sustained VT induced toring of root-mean-square voltage, current, and imped- 
degree of prematurity of the ventricular electrogram predicting successful ablation. The earliest point found in the one patient whose VT was not ablated (patient 9) was 50 msec before the onset of the QRS complex. There was no correlation between early endocardial activation and inducibility of VT at the electrophysiology study. Furthermore, endocardial activation at the successful ablation site was always earlier than that at unsuccessful sites in patients requiring more than one RF pulse. (See Table 1 .)
Success Rate
VT was eliminated in all patients whose arrhythmia arose from the right ventricular outflow tract (either anteroseptal, anterior, or anterolateral locations) ( Figures  2 and 3A) . Similarly, VT in the one patient with VT arising from a posteroseptal mid-left ventricular region ( Figure 3C ) was successfully ablated. Of the three VTs that arose from a region adjacent to the His bundle, two were ultimately successfully ablated ( Figures 3B and 4-6) . In patient 9, VT remained inducible and recurred spontaneously despite multiple ablation attempts. This patient was re-treated with flecainide with suppression of spontaneous VT and has since remained asymptomatic. Another patient with apparent ablation failure (patient 6) ultimately had no inducible VT at follow-up study and no spontaneous VT (see "Follow-up"). Patient 11 required two sessions to eliminate his VT (Table 1) . Thus, VT was eliminated with catheter ablation by using RF energy in 15 of 16 patients, a 94% success rate. There were no complications in any of the 16 patients.
Radiofrequency Energy Delivery
The mean RF voltage in this series was 58±6 V and the mean current was 581±62 mA, giving a mean power of 34 W. (See Table 1 .) The mean number of RF pulses delivered in the 15 successful ablations was 5.8±6, although the overall mean was 8.1 ± 11 pulses (the patient in whom RF energy failed to eliminate VT received 43 pulses before termination of the procedure). A median of three pulses was required for successful elimination of VT in this series, possibly a more meaningful number in view of the skewed number of pulses required in the overall series. The mean duration of RF energy application before elimination of the marker arrhythmia (VT or PVCs) could be adequately assessed in six patients and averaged 8 seconds, ranging from 3 to 30 seconds. Importantly, the ablation was never successful if there was inconsistent capture during high-output pacing, probably reflecting poor catheter contact with endocardium ( Figure 5 ).
Cardiac Enzymes
Among the 16 patients, the mean total CPK rise was 256±265 units, CPK-MB rise 5+3%, and CPK-MB total 18±8 units (reference range, <180 IUll, <5%, and <9 IU/l, respectively). The maximal CPK rise occurred [8] [9] [10] [11] [12] hours after the ablation procedure. VT) on an ambulatory ECG recording 4 weeks after ablation. He has occasional palpitations, but his episodes of presyncope were entirely eliminated.
Signal-Averaged ECGs
Discussion New Observations
The findings described in this report demonstrate that VT in patients without structural heart disease (idiopathic VT) can be safely eliminated with RF energy delivered through a catheter with a high degree of efficacy. It did not matter whether the patient presented with palpitations, presyncope, or syncope. Furthermore, RF catheter ablation successfully eliminated VTs from several locations, including three separate regions in the right ventricular outflow tract, the right ventricular inflow tract, and in one patient, from a site in the left ventricle. Although the follow-up duration is relatively short, the frequency with which the patients in this study had spontaneous VT suggests that an early cure in these patients is likely to be a long-term cure as well. Importantly, the success rate was not affected by whether VT at electrophysiology study was sustained, nonsustained, or even if only PVCs of the same ECG morphology as the VT could be targeted for ablation. In addition, no proarrhythmic effect of RF energy delivery could be identified by programmed ventricular stimulation or signal-averaged ECG 6 weeks after ablation, and no complications occurred from the ablation procedure. Myocardial enzyme rise was minimal, and no wall motion abnormalities resulted.
Technical Considerations
We did not find it necessary in these patients to identify an area of slow conduction by trying to find regions of entrainment or concealed entrainment. 16 The ablation attempts were often complicated by the fact that VT, previously frequent or sustained, was nonsustained or infrequent at the time of ablation. Eight patients presented with spontaneous sustained VT, but only five had inducible or spontaneous sustained VT at the time of ablation. In five patients (patients 7, 10, 14, 15, and 16), PVCs were the target arrhythmia at the ablation session ( Figure 4) . Sedation used at the time of study, catheter trauma, or other factors may have affected the VT prevalence. Fortunately, these "fragments of the arrhythmia" (nonsustained VT or PVCs) were suitable targets for ablation in these patients and did not hinder success, but they did prolong the duration of the procedure, potentially adding a small risk.
Implications for Ventricular Tachycardia Mechanism
The mechanism responsible for VT in patients without structural heart disease is not known and may be multiple.21-25 37, 38 Importantly, however, it has been previously demonstrated that the presumed mechanism of VT did not alter the ablation success when directcurrent energy was used.25 In the present study, attempts to delineate VT mechanism were confounded by many spontaneous terminations of sustained VT and the frequent occurrence of only nonsustained VT at the time of electrophysiology study. The heterogeneity of the presenting arrhythmias and induction protocols required for initiation of VT at the ablation sessions strongly suggests that different mechanisms of VT were operative in our patient population and that RF energy, like direct-current energy,25 delivered through a catheter, can potentially eliminate VT of any mechanism in a patient without structural heart disease.
We were able to make observations that may impact on an understanding of the mechanisms, however. Earliest endocardial activation times (mean, 39 msec before the onset of the earliest QRS) were considerably later than those found in patients with sustained VT caused by coronary artery disease (50-100 msec). '3-15 25 Thus, it is likely that the VT arose in or close to the endocardium. It is possible that the RF energy in the thin-walled right ventricle burned a larger percentage of transmural myocardium compared with similar ablations in patients with coronary artery disease and VT arising from the left ventricle. However, the successful ablation in patient 5 (left ventricular VT) and the large number of VTs arising from septal regions of the right ventricle (anteroseptal location) makes this explanation less likely because a large mass of myocardium (the septum) may have been present in the region of VT in these patients. Naturally, one cannot state whether the electrical (and possibly anatomical) abnormality is congenital or acquired.
Limitations
Why a given RF pulse failed to eliminate VT in an individual patient is not identified in this study. One can speculate that the catheter is not at the critical portion of the circuit or that catheter contact is inadequate. 36 The one patient in whom RF energy failed to eliminate VT (patient 9) had excellent pace maps and very early endocardial activation times. We presumed that catheter contact was inadequate, but intramyocardial or epicardial origins of his VT or suboptimal catheter location may have been responsible for the failure.
This study does not compare the relative efficacy or safety of RF and direct-current catheter ablation. A previous study25 has suggested high efficacy and safety with the use of direct-current ablation. Our data suggest that similar results may be obtained with RF energy. Potential advantages of using RF energy versus directcurrent shocks are lack of need for general anesthesia, ability to safely deliver multiple ablation applications, lack of hemodynamic embarrassment, no damage to the ablation catheter caused by energy delivery, better control of delivered energy, and a more homogeneous lesion (and thus less risk of arrhythmogenicity). The theoretical advantages of RF ablation might make it preferable to direct-current ablation in this patient population; a randomized comparison of the two techniques would be of interest. Energy sources that result in larger or more penetrating lesions (for example, direct-current countershock or microwave energy) may prove necessary for successful VT ablation in patients with structural heart disease.
Conclusions
RF catheter ablation of VT in patients without structural heart disease is feasible and safe. It is our judgment that RF ablation may be considered as early therapy in these patients and perhaps as first-line therapy in selected, highly symptomatic patients.
Addendum
Since this article was submitted, one additional patient has undergone RF catheter ablation for sustained VT. This was a 27- 
